By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Arno Therapeutics 

30 Two Bridges Road
Suite 270
Fairfield  New Jersey  07004  U.S.A.
Phone: 862-703-7170 Fax: 973-227-5759


Company News
Arno Therapeutics Announces Three Poster Presentations At Upcoming American Association for Cancer Research Annual Meeting 2015 4/13/2015 8:03:09 AM
Arno Therapeutics Reports Fourth Quarter 2014 Financial And Business Update 4/1/2015 11:56:05 AM
New Data Supporting Arno Therapeutics' HDAC Inhibitor AR-42 Published In The Journal of Urology 3/24/2015 7:27:49 AM
Arno Therapeutics To Present At 11th Annual Noble Equity Conference 1/8/2015 1:21:15 PM
Arno Therapeutics Doses First Patient In Expansion Stage Of Modified Phase 1/2 Trial Evaluating Onapristone In Progesterone Receptor Positive Tumors 12/10/2014 7:22:54 AM
Arno Therapeutics To Present Data Further Validating Diagnostic Development Of CDX For Onapristone At San Antonio Breast Cancer Symposium 2014 12/9/2014 1:06:42 PM
Arno Therapeutics Appoints Alexander Zukiwski, M.D. To Board Of Directors 12/5/2014 9:23:41 AM
Arno Therapeutics To Present At LD Micro Conference 2014 11/24/2014 1:47:31 PM
Arno Therapeutics Reports Third Quarter 2014 Financial And Business Update 11/17/2014 10:49:00 AM
Arno Therapeutics' Executive Selected To Present At 5th Annual Clinical Affairs And Regulatory Approvals For Diagnostics Conference 10/29/2014 7:53:58 AM